Dabigatran in secondary stroke prevention: clinical experience with 106 patients.

Alicia DeFelipe-MimbreraAraceli Alonso CánovasMarta GuillánConsuelo MatuteSainz de la Maza SAntonio CruzRocío VeraJaime Masjuan

Published in: BioMed research international (2014)

Dabigatran etexilate was safe and effective in secondary stroke prevention in clinical practice, including a small number of patients with previous history of CH.

Keyphrases

atrial fibrillation
end stage renal disease
clinical practice
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
ionic liquid